References
- politique pharmaceutique Nationale [National Pharmaceutical Policy] [Internet]. Morocco: the Moroccan Ministry of Health; 2015 [cited 2017 Dec 20]. Available from www.sante.gov.ma.French
- Barthélémy KD. Demographic, epidemiological, and health transitions: are they relevant to population health patterns in Africa? Glob Health Action. 2014;7:22443.
- HYGINO J La gestion de l’approvisionnement pharmaceutique [Pharmaceutical supply management] [Internet]. Morocco. [cited 2017 Dec 20]. Available from: www.ondh.ma. French.
- Ouachi Z, Allenet B, Chouchane N, et al. Organisation du processus de référencement des médicaments au niveau d’établissements de santé hospitaliers: revue de la littérature internationale [Formulary decision-making process in hospitals: literature review]. Hosp Clin Pharm. 2011 ;46:263–272. French.
- Stratégie sectorielle de santé 2012-2016 [sectoral health strategy 2012-2016] [Internet]. Morocco: the Moroccan Ministry of Health; March 2012 [cited 2017 Dec 20]. Available from: www.sante.gov.ma French.
- Centre Hospitalier Universitaire IBN SINA [IBN SINA University Medical Center] [Internet]. Morocco; [cited 2017 July 25]. Available from:http://www.churabat.ma/index.php/rapports-d-activite. French.
- American Society of Health-System Pharmacists (ASHP). Statement on the pharmacy and therapeutics committee and the formulary system. Am J Hosp Pharm. 2008;65:2384–2386.
- Haute Autorité de Santé [High Authority of Health] [Internet]. France. [cited 2017 Mar 10]. Available from: https://www.hassante.fr/portail/jcms/r_1506267/fr/le-service-medical-rendu-smr-et-lamelioration-du-service-medical-rendu-asmr French.
- Base de données publique des médicaments [Public Drug Database] [Internet]. France. [ updated: 2018 Mar 30; cited 2017 Mar 10]. Available from: http://base-donnees-publique.medicaments.gouv.fr/ French.
- WHO Collaborating Centre for Drug Statistics Methodology [Internet]. Norway; [ updated: 2018 Feb 23; cited 2017 Feb 26]. Available from: https://www.whocc.no/atc/structure_and_principles/
- MYHIE L. Acheteurs-publics: le bureau virtuel des acheteurs publics [Public purchasers: the virtual office of the public purchasers] [Internet]. France: Pyxis support. 2006 [cited 2017 Feb 26]. Available from http://www.acheteurs-publics.com/marches-publics-encyclopedie/attribution-du-marche French.
- MedicineNet.com [Internet]. New York: MedicineNet, Inc. WebMD LLC; [ updated 2017 August 24; cited 2017 Feb 2017]. Available from https://www.medicinenet.com/biologics_biologic_drug_class/article.htm
- European Medicines Agency [Internet]. United Kingdom. [cited 2017 Feb 26]. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/general/general_content_001832.jsp&mid=WC0b01ac0580bb8fda
- World Health Organization [Internet]. Geneva. [cited 2017 Jan 14]. Available from: http://www.who.int/topics/essential_medicines/en/
- Ministère de la santé [Ministry of Health] [Internet]. Morocco. [cited 2017 Jan 14]. Available from: http://www.sante.gov.ma/Medicaments/PHCS/Pages/default.aspx French.
- World Health Organization [Internet]. Geneva. [cited 2017 Jan 14]. Available from: http://www.who.int/medicines/publications/essentialmedicines/fr/
- European Medicines Agency [Internet]. United Kingdom. [cited 2017 Feb 26]. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/special_topics/document_listing/document_listing_000335.jsp&mid=WC0b01ac0580514d5c
- Agence Nationale de l’Assurance Maladie [National Agency of Health Insurance] [Internet]. Morocco. [cited 2017 Jan 11]. Available from: http://www.anam.ma/regulation/guide-medicaments/recherche-de-medicaments-par-nom/. French.
- Ministère de l’économie et de finances [Ministry of Economy and Finance] [Internet]. Morocco. [cited 2017 Dec 25]. Available from: https://www.finances.gov.ma/Docs/2014/depp/decret_2_12_349. pdf. French.
- Référentiel de pharmacie hospitalière [Referential of hospital pharmacy].Société française de pharmacie clinique [French Society of Clinical Pharmacy]. Paris: SFPC; 1997. p. 45–53. French.
- Weekes LM, Day RO. The application of adverse drug reaction data to drug choice decisions made by pharmacy and therapeutics committees. Drug Saf. 1998;18(3):153–159.
- Management sciences for health. part III, chapter 45: hospital pharmacy management. Geneva Switzerland: World Health Organization; 2012.
- Fijn R, Brouwers JR, Knaap RJ, et al. Drug and Therapeutics (D & T) committees in Dutch hospitals: a nation-wide survey of structure, activities, and drug selection procedures. Br J Clin Pharmacol. 1999;48:239–246.
- Ouachi Z, Allenet B, Chouchane N, et al. Drug selection for formularies in French hospitals. Pharm Hosp. 2010;45:57–65.
- Segal R, Pathak DS. Formulary decision making: identifying factors that influence P&T committee drug evaluations. Hosp Formul. 1988;23:174–178.
- Bootman JL, Townsend RJ, McGhan WF. Principles of Pharmacoeconomics. Cincinnati, OH: Harvey Whitney Books Company; 1991.
- Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submission to the BMJ. Br Med J. 1996;313:275–282.
- Sanchez LA. Pharmacceconomics and formulary decision making. Pharmacoecon. 1996;9(Sl):16–25.
- Mullins CD, Cooke CE, Cook JL. Applications of pharmacoeconomic for managed care pharmacy. J Manag Care Pharm. 1997;3(6):720–729.
- Alsultan MS. The role of pharmacoeconomics in formulary decision making in different hospitals in Riyadh, Saudi Arabia. Saudi Pharm J. 2011 Jan;19(1):51–56.
- Dukes MNG. Drug Utilization Studies: methods and Uses. Finland: WHO Regional Publications; 1993. p. 221. European Series No. 45.
- Alsirafy SA, Ibrahim NY, Abou-Elela EN. Opioid consumption before and after the establishment of a palliative medicine unit in an Egyptian cancer centre. J Palliat Care. 2012;28(3):135–140.
- Zin CS, Chen LC, Knaggs RD. Changes in trends and pattern of strong opioid prescribing in primary care. Eur J Pain. 2014;18(9):1343–1351.
- Berterame S, Erthal J, Thomas J, et al. Use of and barriers to access to opioid analgesics: a worldwide, regional, and national study. Lancet. 2016;387(10028):1644–1656.
- Xiang C, Shu-Guang Z, Xuan X, et al. iATC-mHyb: a hybrid multi-label classifier for predicting the classification of anatomical therapeutic chemicals. Oncotarget. 2017;8(No. 35):58494–58503.
- Sisay M, Mengistu G, Molla B, et al. Evaluation of rational drug use based on World Health Organization core drug use indicators in selected public hospitals of eastern Ethiopia: a cross sectional study. BMC Health Serv Res. 2017;17:161.
- Laing R, Waning B, Gray A, et al. 25 years of WHO Essential Medicines List: progress and challenges. Lancet. 2003;361:1723–1729.
- Milovanovic DR, Pavlovic R, Miroslav F, et al. Public drug procurement: the lessons from a drug tender in a teaching hospital of a transition country. Eur J Clin Pharmacol. 2004;60:149–153.
- Jarrett S, Dingermann T. Biosimilars are here: a hospital pharmacist’s guide to educating health care professionals on biosimilars. Hosp Pharm. 2015 Nov;50(10):884–893.
- Blackstone EA, Fuhr JP. The Economics of Biosimilars. Am Health Drug Benefits. 2013 Sep-Oct;6(8):469–478.
- Hoffman JM. A health system pharmacist’s guide to biosimilars: regulatory, scientific, and practical considerations. USA: American Society of Health-System Pharmacists; 2013.
- Griffith N, McBride A, Stevenson JG, et al. Formulary selection criteria for biosimilars: considerations for US health-system pharmacists. Hosp Pharm. 2014 Oct;49(9):813–825.